Researcher in Pharmacometrics

My main research interest is model-informed drug development and dose-optimisation for treating infectious diseases, including malaria, tuberculosis, dengue fever, schistosomiasis, leishmaniasis and onchocerciasis. I primarily used population pharmacokinetic-pharmacodynamic and physiologically based pharmacokinetic (PBPK) modelling approaches to address critical clinical questions, such as preclinical translational PK-PD, FIH dose prediction, clinical DDI assessment, optimization dose in specific population, pediatric extrapolation etc., I have published over 40 papers in peer-reviewed journals. These publications cover a range of topics, from methodology advancements in pharmacokinetic modelling to applied studies on the pharmacodynamics of treatments for infectious diseases.